Navigation Links
Royalty Pharma Statement Regarding Elan Proposal
Date:3/6/2013

r the combined company following the Possible Offer; statements concerning any future Irish, U.S. or other economic environment or performance; statements about strategic goals, competition, regulation, regulatory approvals, dispositions and consolidation or technological developments in the financial services industry; and statements of assumptions underlying such statements.

Forward looking statements only speak as of the date on which they are made, and the events discussed in this announcement may not occur. Subject to compliance with applicable law and regulation, Royalty Pharma is not under any obligation to update publicly or revise forward looking statements, whether as a result of new information, future events or otherwise.

No Profit Forecast / Asset Valuations
No statement in this announcement constitutes a profit forecast for any period, nor should any statement be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for either Royalty Pharma or Elan as appropriate. No statement in this announcement constitutes an asset valuation.APPENDIX I: DefinitionsThe following definitions apply throughout this announcement unless the context otherwise requires:"Alkermes Shares"

the 7.75 million ordinary shares of Alkermes plc sold by Elan Science Three Limited on

February 6, 2013;

 "BofA Merrill Lynch"

Merrill Lynch International, a subsidiary of Bank of America Corporation;

 "Biogen"

Biogen Idec Inc.;

 "Board of Elan"

the board of directors of Elan at the date of this announcement;"Broker Median Price

Target"

the median of the price targets given by the brokers named in the Sources and Bases section

that have published price targets following the announcement of the Tysabri Transaction on

February 6, 2013 and prior to the Proposal Announc
'/>"/>

SOURCE RP Management, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
2. Cowen Healthcare Royalty Partners Raises $1 Billion
3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
6. AVANIR Pharmaceuticals To participate in two conferences in March
7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Portal Solutions , a ... on Microsoft Office 365 and SharePoint platforms , today ... program for being one of the region’s fastest-growing mid-sized companies ... growth. , “To be recognized a second year in ...
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces the ... office space for Shire a leading biopharmaceutical company, at Two ... | RBJ,s Robert Richards , president, and Brian ... for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... Cambridge Semantics, the leading provider of smart data ... was a record-breaking year across the board for the company. ... Data Platform and our Smart Data solutions, our customers were ... which led to record growth for the company in 2014,” ...
(Date:1/22/2015)... Crystal Diagnostics (CDx) Xpress System, a rapid ... AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing E. coli ... to as STEC or the “Big-6”) as well as Escherichia ... per 325 g of raw ground beef and raw beef ...
Breaking Biology Technology:Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 2Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 3Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Cambridge Semantics Announces Record Results for 2014 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2
... research team at the University of Wisconsin-Madison will ... study the impact of digital media on youth culture, learning, ... support 24 national studies of different aspects of the digital ... MacArthur is actually trying to do, with this grant to ...
... program authorized by the Circuit Court of Wisconsin ... consumers and businesses that acquired Microsoft software ... nearly $224 million back to them as part of ... software giant. , ,The notices are the result of ...
... - For Milwaukee's forthcoming wireless Internet service, everything seems to ... has finalized a contract with Midwest Fiber Networks, LLC ... off the hook because Midwest Fiber will invest the $20 ... begun to install antennas in a demonstration area containing ...
Cached Biology Technology:UW gets $3M to explore educational gaming 2UW gets $3M to explore educational gaming 3Microsoft to distribute $224M as part of settlement 2Will wireless Internet bypass the central city? 2Will wireless Internet bypass the central city? 3Will wireless Internet bypass the central city? 4
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. One major ... multimodal biometric systems. Multimodal biometric systems utilize more than ...
(Date:12/10/2014)... Baptist Medical Center today announced plans for a new medical ... $50 million capital project is part of a larger capital ... The medical education building will be located in the ... 525@vine in Wake Forest Innovation Quarter. Construction will begin immediately ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Michigan have identified a new potential therapeutic target for ... therapy to statins. Scientists in the lab ... the action of a gene responsible for transporting a ... to remove cholesterol from the blood in mice. Trapping ...
... the Seventh Framework Programme (FP7) of the European Commission, ... countries, has received a 8M funding to enhance ... European ,biobanks,. The project represents the next ... and Biomolecular Resources Research Infrastructure), which was operational from ...
... the gene HER2 these are the big three markers ... Annual Meeting 2013 adds a fourth: androgen receptors. "This ... toward the addition of the androgen receptor as potential target ... breast cancer," says Jennifer Richer, PhD, investigator at the University ...
Cached Biology News:U-M researchers find new way to clear cholesterol from the blood 28 M € from EU to enhance access by scientists to the largest European 'biobanks' 2AACR news: Studies show increasing evidence that androgen drives breast cancer 2
MOUSE ANTI POLY (ADP-RIBOSE) Immunogen: Purified poly (ADP-ribose) polymer, 10-50 unit chain length...
This issue concentrated on the purification of proteins for specific purposes (i.e. large-scale purification, purification for therapeutic use, etc.)...
... A.D. Smith et.al. (1997) • ... on current biochemistry & molecular ... 17,000 headwords. Entries give details ... processes in which they are ...
Edited by D.M. Gersten (1996) Provides comprehensive descriptions of the techniques available for analytical gel electrophoresis of proteins and offers clear step-by-step protocols for all of the m...
Biology Products: